# Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years

> **NCT00718120** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 110 (actual)

## Conditions studied

- Influenza Vaccines

## Interventions

- **BIOLOGICAL:** Fluviral®

## Key facts

- **NCT ID:** NCT00718120
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07-18
- **Primary completion:** 2008-08-09
- **Final completion:** 2008-08-09
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2019-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00718120

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00718120, "Immunogenicity and Safety Study of GSK Biologicals' Fluviral® (2008 - 2009 Season) in Adults Over 18 Years". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00718120. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*